Slowing of myopia progression in children confirmed
Menicon Co, Ltd, a leading contact lens manufacturer headquartered in Nagoya, Japan, is pleased to announce the publication of the one-year results of the PROTECT (Progressive Myopia Treatment Evaluation Contact Lens Trial) study. This study evaluates the effectiveness of the Menicon Bloom Day contact lens in the treatment of myopia in children.
The PROTECT study conducted by Visioneering Technologies, Inc., the manufacturer of the Menicon Bloom Day™ contact lens, shows promising results for the treatment of myopia in children and adolescents:
- Treatment effect on refractive error: 0.41 dpt compared to the control group.
- Treatment effect on axial length: 0.17 mm compared to the control group.
- Average change in axle length: 0.11 mm.
- Percentage of subjects without significant progression of myopia: 64%.
These results confirm previous findings analyzing six years of data* and another independent study** and underline the effectiveness of the Menicon Bloom Day lens as an effective treatment for slowing the progression of myopia in children.
Peter Nijhuis, Director Myopia Management Business Division and Menicon Holdings B.V., commented on the results: "We are thrilled that the 1-year data confirms our confidence in the efficacy of Menicon Bloom Day in slowing myopia progression in myopic children and adolescents. Our goal is to provide eye care professionals with effective tools for myopia management and these results support our commitment."
About Menicon
Menicon Co, Ltd, founded in 1951 by Kyoichi Tanaka, is Japan's first and largest contact lens manufacturer. The company is represented in more than 80 countries and is dedicated to all aspects of the contact lens business, including research and development.
About Visioneering Technologies Inc.
Visioneering Technologies Inc (VTI) is an innovative eye care company dedicated to redefining vision. Since its founding in 2008, VTI has brought together clinical, marketing, manufacturing and regulatory experts from leading eye care companies to develop new solutions for presbyopia, myopia and astigmatism.
Sources:
* Cooper J, O'Connor B, Aller T, Dillehay SM, Weibel K, Benoit D. Reduction of Myopic Progression Using a Multifocal Soft Contact Lens: A Retrospective Cohort Study. Clin Ophthalmol. 2022 Jul 4;16:2145-2155.
** Cooper J, Aller T, Smith EL 3rd, Chan K, Dillehay SM, O'Connor B. Retrospective Analysis of a Clinical Algorithm for Managing Childhood Myopia Progression. Optom Vis Sci. 2023 Jan 1;100(1):117-124.
